Hjs. Stewart et al., REGULATION OF RAT SCHWANN-CELL P-O EXPRESSION AND DNA-SYNTHESIS BY INSULIN-LIKE GROWTH-FACTORS IN-VITRO, European journal of neuroscience, 8(3), 1996, pp. 553-564
Myelination by Schwann cells is likely to be regulated in vivo by posi
tive and negative epigenetic factors. In Vitro, the positive regulatio
n of myelin differentiation, in particular expression of the major mye
lin protein P-0, can be mimicked by cAMP elevating agents, while serum
, transforming growth factor (TGF)beta s, and fibroblast growth factor
(FGF)2 have been shown to exert a negative effect on this differentia
tion. Growth factors which promote P-0 induction have not, however, be
en identified previously. Using a forskolin concentration (0.4 mu M) w
hich alone produces little P-0 mRNA or protein induction, we show that
insulin-like growth factor (IGF)-I, IGF-II and high concentrations of
insulin promote high levels of P-0 induction, although in the absence
of forskolin they have no effect. Another event related to Schwann ce
ll differentiation, induction of galactocerebroside expression in resp
onse to cAMP analogues, is also potentiated by IGFs. In a different co
ntext, IGFs regulate Schwann cell DNA synthesis. We find that in defin
ed medium forskolin plus FGF2, TGF beta or platelet-derived growth fac
tor (PDGF) BE causes minimal DNA synthesis in the absence of IGFs and
that IGFs act as potent mitogens under these conditions. IGFs also pot
entiate DNA synthesis induced by beta isoforms of neu-differentiation
factors (NDFs), although in this case considerable DNA synthesis occur
s even in the absence of IGF. These results show that IGFs can act as
powerful stimulators of both proliferation and differentiation in Schw
ann cells, and that the total growth factor input determines which of
these pathways IGFs will promote.